Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Hellenic Cooperative Oncology Group (HeCOG) is a prominent non-profit scientific organization based in Athens, Greece, specializing in clinical and translational oncology research. Established in 1990, the group functions as a network of oncology departments from major hospitals across Greece and Cyprus, facilitating multicenter clinical trials. HeCOG's primary mission is to improve cancer treatment outcomes through the rigorous evaluation of novel therapeutic agents and the discovery of predictive biomarkers. The organization maintains a sophisticated central laboratory and an extensive biobank, which support its robust translational research initiatives. By collaborating with international research networks and the pharmaceutical industry, HeCOG plays a vital role in advancing personalized medicine and standardizing oncological care in the region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HeCOG.